1. Home
  2. HUT vs TECH Comparison

HUT vs TECH Comparison

Compare HUT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hut 8 Corp.

HUT

Hut 8 Corp.

HOLD

Current Price

$87.48

Market Cap

14.1B

Sector

Finance

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$72.45

Market Cap

11.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUT
TECH
Founded
2011
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
11.3B
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
HUT
TECH
Price
$87.48
$72.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
11
Target Price
$65.20
$71.82
AVG Volume (30 Days)
4.9M
2.9M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
0.62%
EPS Growth
N/A
152.17
EPS
N/A
1.16
Revenue
$235,118,000.00
$1,215,039,000.00
Revenue This Year
$161.69
$2.49
Revenue Next Year
N/A
$6.40
P/E Ratio
N/A
$62.40
Revenue Growth
44.79
N/A
52 Week Low
$24.20
$43.20
52 Week High
$140.80
$72.62

Technical Indicators

Market Signals
Indicator
HUT
TECH
Relative Strength Index (RSI) 48.60 67.84
Support Level $87.39 $71.89
Resistance Level $112.33 $72.62
Average True Range (ATR) 6.68 0.22
MACD 0.62 -0.26
Stochastic Oscillator 65.76 61.29

Price Performance

Historical Comparison
HUT
TECH

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: